- Concept UI
- M0004295
- Registry Numbers
- 0
- Scope Note
- Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
- Terms
-
Cholinesterase Inhibitors
Preferred Term
Term UI
T008158
Date01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1965)
-
Anti-Cholinesterase
Term UI
T000998051
Date11/20/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anticholinesterase Agent
Term UI
T000998053
Date11/20/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anticholinesterase Drug
Term UI
T000998054
Date11/20/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Cholinesterase Inhibitor
Term UI
T000996486
Date11/15/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anticholinesterase
Term UI
T000996435
Date11/14/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anticholinesterase Agents
Term UI
T008157
Date03/29/1974
LexicalTag
NON
ThesaurusID
UNK (19XX)
-
Anti-Cholinesterases
Term UI
T008159
Date02/04/1994
LexicalTag
NON
ThesaurusID
NLM (1995)
-
Anticholinesterases
Term UI
T008160
Date02/04/1994
LexicalTag
NON
ThesaurusID
NLM (1995)
-
Anticholinesterase Drugs
Term UI
T008161
Date05/18/1995
LexicalTag
NON
ThesaurusID
NLM (1996)